CTSB and Cognitive impairment: To further elucidate the alterations in miR‐96‐5p/CTSB levels in the serum of AD patients, we collected serum samples from 48 healthy controls (HC), 30 mild cognitive impairment (MCI) patients, and 52 patients with mild to moderate AD (Table 1).